Among end-stage renal disease (ESRD) patients on hemodialysis, death from withdrawal from lifesustaining dialysis is increasingly common. The present study's objective was to examine depression as a potential risk factor for hemodialysis withdrawal. Two hundred forty ESRD hemodialysis (133 male and 107 female) patients were followed for an average of 4 years after depression symptom assessment. Of these, 18% withdrew from dialysis. Using multivariate survival analysis and after controlling for the effects of age ( p Ͻ .001) and clinical variables, the authors found that level of depression symptoms was a unique and significant predictive risk factor for the subsequent decision to withdraw from dialysis ( p Ͻ .05). The potential impact that depression may have on the decision to withdraw from hemodialysis should be considered by health care providers, patient families, and patients.
The approximately 400,000 end-stage renal disease (ESRD) patients in the United States face a life-threatening, chronic illness. Prior to the widespread availability of hemodialysis in the 1970s, a diagnosis of ESRD meant almost certain death due to the accumulation of excess fluid, metabolic toxins, and electrolytes in blood and bodily tissues that follows renal failure. Currently, approximately 65% of ESRD patients are treated with hemodialysis (U.S. Renal Data System [USRDS], 2004). As renal dialysis has become the standard of care for most ESRD patients, deliberate termination from the treatment has also become more common among patients in recent years. Rates of termination of lifesupporting hemodialysis treatment have increased considerably over the last few decades. Withdrawal from dialysis prior to death is currently the second leading cause of death among dialysis patients (USRDS, 2004) . Among older Caucasian patients, dialysis termination rates increased 10% each year throughout the 1980s (Nelson, Port, Wolfe, & Guire, 1994) . The increased rates may be in part due to an improved reporting protocol for dialysis termination as many instances of death from dialysis termination may have previously gone unreported (Leggat, Bloembergen, Levine, Hulbert-Shearon, & Port, 1997) . According to the USRDS 2004 annual data report, approximately 20% of dialysis patients withdraw from dialysis prior to death (USRDS, 2004) . In addition, the decision to end dialysis treatment has increasingly been initiated by patients and their families in recent years, as compared with physician-initiated decisions of the past (Coneen et al., 1998; Husebye & Kjellstrand, 1987) .
Factors Influencing Dialysis Termination
Despite the increasing prevalence and certain fatal consequences of this action, factors mediating dialysis termination are not well understood. Medical factors (e.g., illness severity) likely play a role to some degree. In one study, new medical complications were found to have preceded the decision to withdraw from hemodialysis treatment in approximately 26% of patients (Roberts & Kjellstrand, 1988) . Chronic medical comorbidity (particularly the presence of diabetes mellitus) also increases the risk for dialysis termination (Bajwa, Szabo, & Kjellstrand, 1996; Leggat et al., 1997; Mailloux et al., 1993) . Specifically, in one study of dialysis withdrawal, Caucasian diabetic patients were found to withdraw 1.8 times as often as Caucasian nondiabetic patients, and Black diabetic patients were found to withdraw 2.3 times as often as Black nondiabetic patients (Leggat et al., 1997) .
A variety of other findings suggests that termination cannot be explained on the basis of medical comorbidity, complications, or disease severity. Gender has been found to correlate with the decision to withdraw (Leggat et al., 1997; Port, Wolfe, Hawthorne, & Ferguson, 1989) . For example, in an analysis of the USRDS database from 1990 to 1995, Leggat et al. (1997) found that women were 25% more likely to withdraw from dialysis than men. In addition, age has consistently been found to play a role in the termination of dialysis. Several studies have found a significantly higher risk for termination among older patients (Mailloux et al., 1993; Nelson et al., 1994; Port et al., 1989) . For example, Mailloux et al. (1993) conducted a 20-year follow-up study of 716 dialysis patients in which the authors found that older patients were twice as likely to withdraw from dialysis as patients less than 60 years of age. Of course, age is often confounded with illness severity, with older patients typically having more comorbidity and more severe illness (National Center for Health Statistics, 2003) .
Ethnic differences in dialysis termination are also clearly present. Caucasian patients have been found to withdraw from dialysis significantly more than Black and Asian American patients (Leggat et al., 1997; Nelson et al., 1994; Port et al., 1989) . Leggat et al. (1997) found that Black and Asian American patients are only half as likely to withdraw from treatment as Caucasians. These demographic differences in dialysis termination rates suggest that non-disease-related factors, including sociocultural factors, likely influence the decision to withdraw from dialysis treatment.
The Role of Depression in Dialysis Termination
The role of other factors potentially influencing dialysis termination, including psychosocial or psychiatric variables, has received scant empirical attention. Most notably, the influence of depressive symptomatology has never been adequately studied in relation to the hemodialysis withdrawal phenomena. Despite this lack of attention, several factors led us to believe that depression may be playing a role in the decision to terminate treatment. First, greater depression symptoms among patients on dialysis have been associated with increased perception that one's illness is intrusive and interferes with important life domains (Devins et al., 1984; Sacks, Peterson, & Kimmel, 1990) . Hemodialysis requires a considerable investment of time and often involves considerable disruption to social, vocational, and familial roles. However, the extent to which the hemodialysis process is perceived as intrusive or disruptive to important life domains diminishing patient quality of life varies across individuals. Perceived intrusiveness is known to be significantly greater among patients reporting higher depressed mood than among other hemodialysis patients (Devins et al., 1984; Sacks et al., 1990) .
Suicidal behaviors (other than dialysis withdrawal) have been noted among depressed ESRD patients at greater rates than that seen among the general population (Kimmel, Weihs, & Peterson, 1993; Shulman, Price, & Spinelli, 1989) . Although preemptive medical treatment termination has not legally been classified as suicide, the influences underlying dialysis treatment termination may very well parallel risk factors for suicidal behavior. Research involving other clinical populations has indicated a relationship between depression and an increased desire for death (Breitbart et al., 2000; Brown, Henteleff, Barakat, & Rowe, 1986; Ganzini, Lee, Heintz, Bloom, & Fenn, 1994) . For example, in a study of 92 terminally ill patients, a desire for a hastened death was significantly associated with elevated self-reports of depressive symptomatology, elevated hopelessness, and clinical diagnosis of depression on the basis of Diagnostic and Statistical Manual of Mental Disorders (4th ed.; American Psychiatric Association, 1994) criteria (Breitbart et al., 2000) . Finally, among the general population, the risk of death from suicide has been established as significantly higher for persons suffering from depressive disorders (Nierenberg, Gray, & Grandin, 2001) .
Only one study to our knowledge has investigated the connection between depression and dialysis treatment termination (Cohen, Dobscha, Hails, Pekow, & Chochinov, 2002) . Although this study failed to find a significant connection between depression and the decision to withdraw, some important limitations were present. In this multisite study, Cohen et al. attempted to identify and evaluate patients for depression after patients had already withdrawn from dialysis. This is a difficult and potentially flawed approach. Depending on the amount of time that elapses between dialysis termination, study enrollment, and depression assessment, the physiological condition of the patient may deteriorate to the point that he or she is unable to provide consent and participate in the study. In fact, Cohen et al. reported that only 29% of patients referred for study participation could be meaningfully evaluated. Many other potential participants in this study were never referred at all or were referred too late to be considered for participation. In all, there were 131 deaths due to dialysis withdrawal across the study period, and only 23 (17.5%) patient depression evaluations were conducted successfully. Moreover, once the decision to terminate life-sustaining treatment has been made, patients may be reluctant to disclose depressive symptomatology for fear of having their decision challenged or in order to help reconcile with themselves that the decision was made of sound mind and for valid reasons (Cohen et al., 2002) .
In the present study, we adopted an alternative approach to evaluating the association between depression and risk of dialysis withdrawal through the utilization of an existing data set. By pooling several existing data sets taken from earlier studies involving depression symptoms among hemodialysis patients (Christensen, Benotsch, Wiebe, & Lawton, 1995; Christensen et al., 2002; Moran & Christensen, 2003; Wiebe & Christensen, 1997) , we were able to examine the prospective relation of depression symptoms to future risk of dialysis withdrawal over an average 4-year period. By examining depression symptoms as a risk factor for future dialysis termination, we believe that we were able to obtain a more representative patient sample and that we avoided many of the problems inherent in assessing depression after a termination decision has already been made.
Present Study
Understanding dialysis termination has become increasingly important as it has become an increasingly common cause of death among ESRD patients. The extent to which patient depression is associated with an elevated risk of dialysis withdrawal has not been adequately evaluated. The central objective of the present study was to examine the prospective association between patientreported symptoms of depression (by using the Beck Depression Inventory [BDI]; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and future risk of withdrawal from dialysis prior to death over an average 48-month period. We considered depression symptom assessments conducted prior to patients reporting a desire to discontinue dialysis and then examined the risk of dialysis withdrawal associated with preexisting depression symptoms.
Method

Patient Sample
Patient data examined in the present investigation were drawn from several earlier studies conducted by our research team at the University of Iowa over a 9-year period (Christensen et al., 1995 (Christensen et al., , 2002 Moran & Christensen, 2003; Wiebe & Christensen, 1997) . All participants were on hemodialysis at the time of depression assessment. The data previously reported for one sample (Christensen et al., 2002) were from assessments of patients before dialysis initiation. For this analysis, we used data for this sample that had been collected at a second time point after patients initiated dialysis as part of an ongoing study. The inclusion criteria for each earlier data collection effort, as previously reported, were that participants had to be 18 years old or older, English speaking, and free of severe cognitive impairment. The patients at the University of Iowa recruitment sites were predominantly Caucasian (greater than 90%). The average response rate for the different study samples was 64%, ranging from 57% to 72% (Chris-tensen et al., 1995 (Chris-tensen et al., , 2002 Moran & Christensen, 2003; Wiebe & Christensen, 1997 ). In total, 256 patients were followed for an average of 47.9 months (range ϭ 0.67Ϫ110 months). Elapsed follow-up time was a function of when depression was initially assessed and either the date of death for those patients who were deceased or January, 2, 2003, the date of our final assessment of patient status. The determination of whether patients died as a result of withdrawing from dialysis treatment was made by examining the Medicare Death Notification form for ESRD patients and/or the patient's clinical record. These sources provided definitive indication of whether a decision had been made to terminate dialysis treatment. At follow-up, 45 patients (18%) had died as a result of withdrawing from dialysis, a rate of withdrawal similar to that found previously in studies (Neu & Kjellstrand, 1986; Port et al., 1989; USRDS, 2004) . Sixteen participants were excluded because of missing data, which resulted in a final sample of 240, including 41 participants who withdrew from dialysis.
Measures
Demographic and clinical characteristics. A range of demographic, clinical, and biochemical characteristics were available to us in the existing data set and were included in a preliminary Cox regression analysis to determine their relation to dialysis withdrawal. Significant predictors of withdrawal were retained as covariates in the primary analysis of dialysis termination. As seen in Table 1 , available demographic and clinical characteristics included age, sex, marital status, education level, diabetic status, and time between first dialysis and date of depression assessment (an indication of disease duration). Biochemical variables included mean values of the following measures assessed over an approximate 2-month period at the time coinciding with depression assessment: serum creatinine, blood urea nitrogen, serum phosphate, serum potassium, and interdialytic weight gain. All five of these biochemical variables have been previously linked with patient survival (from causes other than dialysis withdrawal; Lowrie & Lew, 1990; Wolcott, Maida, Diamond, Nissenson, 1986) . Serum phosphate and interdialytic weight gain levels reflect, in part, patient adherence to the prescribed dietary and medication regimen patients are instructed to follow.
BDI. Depressive symptomatology was assessed through the BDI (Beck et al., 1961) , a well-validated measure that consists of 21 items, each representing a category of depressive symptoms. The BDI has been shown to consist of two factors, one composed of cognitive and emotional symptoms of depression, the other composed of somatic complaints often associated with depression (Peck, Smith, Ward, & Milano, 1989) . The somatic factor is composed of items reflecting fatigue, appetite loss, and insomnia, as well as other items that can reflect the physical symptoms or vegetative signs of ESRD and uremia rather than depression. As in other studies involving the BDI and this population (e.g., Christensen, Wiebe, Smith, & Turner, 1994) , the nonsomatic-cognitive factor was examined separately in the survival analysis to avoid symptom overlap between depression and ESRD (Craven, Rodin, Johnson, & Kennedy, 1987; Hinrichsen, Lieberman, Pollack, & Steinberg, 1989; Kimmel et al., 1993) . Key analyses were repeated by using the full-scale BDI, however. The nonsomatic subset of BDI items demonstrated good internal consistency for this sample (␣ ϭ .86), as did the total BDI scale (␣ ϭ .85).
Overview of the survival analysis. We performed multivariate survival analysis by using the Cox proportional hazards regression procedure program from SPSS-Windows, Release 10.1. This procedure considers the effect of multiple survival predictors simultaneously and, unlike traditional multiple regression, allows for the inclusion of censored survival times (Cox, 1972) .
In a preliminary analysis, we entered all demographic and clinical variables into the Cox model simultaneously. Those variables identified as significant predictors of withdrawal ( p Ͻ .05) were retained as covariates in the primary analysis. In the primary analysis, the BDI nonsomatic score was then entered into the Cox model along with any previously identified significant demographic and clinical predictors of withdrawal. Death from dialysis withdrawal served as the dependent variable for both analyses. The Note. BDI ϭ Beck Depression Inventory; BUN ϭ blood urea nitrogen. a n ϭ 236. b n ϭ 234. c n ϭ 218.
primary analysis was then repeated by using the total BDI score in place of the nonsomatic score.
Results
Clinical and Demographic Variables
In the preliminary Cox regression analysis, all clinical and demographic variables described earlier were entered into the equation simultaneously. As seen in Table 2 , the overall regression model was significant, 2 (12, N ϭ 210) ϭ 41.00, p Ͻ .001. Significant, unique effects were obtained for age, 2 (1, N ϭ 210) ϭ 17.14, p Ͻ .001; serum creatinine, 2 (1, N ϭ 210) ϭ 7.28, p Ͻ .01; and serum phosphate, 2 (1, N ϭ 210) ϭ 5.36, p Ͻ .05. The pattern of effects from the preliminary Cox regression analysis indicated that older patient age, lower serum creatinine, and higher serum phosphorus were all predictors of increased likelihood of withdrawing from dialysis. The regression coefficients ("hazards") for these variables indicated that a 1-year increase in patient age was associated with a 6.7% increase in risk of withdrawing. A 1-mg/dL decrease in serum creatinine was associated with a 23% increase in risk of withdrawing, and a 1-mg/dL increase in phosphorus was associated with a 41% increase in risk of withdrawing. These three predictors were all included in the primary survival analysis, along with patient nonsomatic BDI score.
1
Primary Analysis
In the primary analysis, age, serum creatinine, and serum phosphate as well as patient nonsomatic BDI score were entered into the Cox regression equation simultaneously. As seen in Table 3 , the overall regression model was significant, 2 (4, N ϭ 239) ϭ 31.86, p Ͻ .001. Significant, unique effects were obtained for age, 2 (1, N ϭ 239) ϭ 12.91, p Ͻ .001; creatinine, 2 (1, N ϭ 239) ϭ 9.24, p Ͻ .01; and nonsomatic BDI score, 2 (1, N ϭ 239) ϭ 6.29, p Ͻ .05. The hazard coefficient indicated that a 1-point increase in BDI nonsomatic total was associated with a 6.4% increase in risk of withdrawing. After exponentiation, the estimated risk of withdrawing from dialysis for patients with relatively high (one standard deviation above the sample mean) nonsomatic BDI scores was 36.4% higher than the rate for patients with average scores on the nonsomatic subset of the BDI.
The primary analysis was repeated by using the BDI total score. The effect of patient total BDI score was again significant and was somewhat stronger than the effect found for the nonsomatic items score, 2 (1, N ϭ 238) ϭ 8.70, p Ͻ .05. The hazard coefficient indicated that a 1-point increase in BDI total score was associated with a 5.2% increase in risk of withdrawing. After exponentiation, the estimated risk of withdrawing from dialysis for patients with relatively high total BDI scores was 42.6% higher than the rate for patients with average scores on the nonsomatic subset of the BDI.
Although the effect of BDI total score on dialysis withdrawal appeared somewhat stronger than the effect involving the nonsomatic symptom subset of the BDI, these two effects were not significantly different ( p Ͼ .10; see Figure 1 ). 2 1 Neither age, time on dialysis, or diabetic status had a significant bivariate association with either total or nonsomatic BDI score (rs ϭ .01-.12, all ps Ͼ .20)
2 When entering the nonsomatic BDI and somatic BDI scores simultaneously into the same regression model, neither had a significant unique effect on dialysis withdrawal. This is not surprising given the high correlation (r ϭ .54) between the two item sets. 
Discussion
The present study is the first to prospectively examine the relationship between patient level of depression symptoms and the decision to withdraw from hemodialysis. Patient depression significantly predicted the subsequent decision to terminate lifesustaining dialysis over an average 48-month follow-up period. This effect persisted after controlling for the effects of age, serum creatinine level, and serum phosphate level. Patients with relatively high scores on the nonsomatic subset of the BDI had a 36.4% increased risk of withdrawing from dialysis over the average 48-month follow-up period.
Although the connection between depression and the wish to terminate life-sustaining treatment has been established among terminally ill patient populations (Blank et al., 2001; Eggar, Spencer, Anderson, & Hiller, 2002; Ganzini et al., 1994) , this was the first study to prospectively evaluate this relationship in ESRD patients on hemodialysis. Although life expectancy for this population is shortened, ESRD is a chronic rather than terminal illness and has a 5-year mortality rate of approximately 50%. One other study to our knowledge has examined the relationship between depression and dialysis withdrawal (Cohen et al., 2002) . In Cohen et al.'s (2002) investigation of dialysis withdrawal and depression, the investigators' assessed depression after the decision to withdraw had already been made and reported to medical staff. The present investigation avoided some of the interpretive and methodological difficulties inherent in that approach by assessing depression in advance of the decision to withdraw from dialysis and following patients prospectively from the time of the depression assessment.
An additional significant finding from the present study is the association of age with the decision to withdraw, with older patients more likely to withdraw from dialysis. This association has been found in previous research as well, including studies by Port et al. (1989) , Nelson et al. (1994) , and Mailloux et al. (1993) . Older age often brings with it increased illness (National Center for Health Statistics, 2003) , which continues to suggest that medical complications likely play some role in the decision to withdraw. However, older age is also associated with increased rates of clinical depression (Blazer, 1993; Lebowitz et al., 1997; Unutzer & Bruce, 2002) .
The association between elevated serum phosphate levels and risk for withdrawal indicated that patients who adhere less to the phosphorus-control regimen (i.e., the reduction of dietary phosphorus and regular administration of phosphate-binder medication) are at greater risk for terminating dialysis. In other words, a less harmful but still clinically important indirect marker of nonadherence predicted a much greater and more direct self-harm behavior in the future, namely, withdrawal from dialysis. Note, however, that when the nonsomatic BDI score was included in the primary analysis, this relationship was no longer statistically significant.
The finding that lower serum creatinine level was associated with an increased risk of dialysis withdrawal likely reflects the fact that in some patients with physically deteriorating or moribund conditions, patient malnutrition, loss of muscle mass, and an accompanying decrease in serum creatinine levels is evidenced (see Bircher, 2000) . This pattern suggests that illness severity or the physiologic condition of the patient certainly plays a role in influencing withdrawal decisions to some degree. However, this role did not obscure the significant effect of depressive symptoms.
The current study failed to find a relationship between diabetic status, an important indicator of comorbidity, and withdrawal from dialysis in this sample. This is notable because diabetes is typically the major source of comorbidity in this population. However, given the limited available archival patient data, we did not assess other potentially important sources of comorbidity, such as cardiovascular disease, nor did we directly assess patients' level of physical functioning. This leaves open the possibility of "third variable" explanations-namely, that depression is related to a more deteriorated physical state, which is in turn related to risk of withdrawal from dialysis. Future research should include more direct measures of physical functioning to more clearly delineate the extent to which the depression effect we have observed is a function of greater illness-related physical impairment among some patients.
The ethnic homogeneity of the study's sample (greater than 90% Caucasian) limits our contribution to understanding dialysis withdrawal among ethnic minorities. However, dialysis withdrawal is known to be much more prevalent among Caucasian patients relative to most ethnic minority groups (Leggat et al., 1997; Nelson et al., 1994; Port et al., 1989) . Still, it will be important for future research to delineate some of the sociocultural or other factors mediating the clear ethnic differences in dialysis withdrawal rates.
There are several reasons why depression may predict a higher likelihood of dialysis withdrawal. One possibility is that feelings of hopelessness lead depressed patients to feel that "enough is enough" and that remaining on dialysis represents a hopeless situation that will not improve. Another reason may be an increase in perceived dialysis-related illness intrusiveness for depressed ESRD patients (Devins et al., 1984) . As illness intrusiveness increases, the patient's quality of life seems diminished, which may contribute to the belief that life on dialysis is not a life worth living. For example, Kimmel et al. (1998) found that illness intrusiveness, as measured with the Illness Effects Questionnaire, was related to reduced length of life. Similarly, direct changes in social, vocational, and familial roles as a result of being on dialysis may be perceived as especially intolerable by patients experiencing depression.
This study contributes to the growing body of research that suggests that depression is an important factor to consider among ESRD patients on hemodialysis. For some patients, the withdrawal decision may be influenced by depression, a condition that may respond to therapeutic efforts. Moreover, research involving other populations has shown that treatment for depression can indeed change patient preferences for such life-supporting treatment (Eggar et al., 2002; Ganzini et al., 1994) . Increasing awareness among health care providers, patients, and their family members of the potential impact depression may have on the decision to cease hemodialysis should be an important part of the management of individuals receiving hemodialysis. Brief depression evaluation and, when appropriate, intervention could potentially have a profound impact on patient outcomes when it comes to this common cause of patient mortality.
